Lise J Estcourt Selected Research

Platelet Transfusion (Blood Platelet Transfusions)

1/2020	Platelet transfusion: Alloimmunization and refractoriness.
11/2019	Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures.
10/2019	The TREATT Trial (TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia): safety and efficacy of tranexamic acid in patients with haematological malignancies with severe thrombocytopenia: study protocol for a double-blind randomised controlled trial.
4/2018	Pathogen-Reduced Platelets for the Prevention of Bleeding in People of Any Age.
1/2018	Prophylactic platelet transfusions prior to surgery for people with a low platelet count.
1/2018	Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.
1/2018	Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia.
1/2017	Pathogen-reduced platelets for the prevention of bleeding.
11/2016	Alternatives to allogeneic platelet transfusion.
10/2016	Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lise J Estcourt Research Topics

Disease

36	Hemorrhage 01/2022 - 09/2010
17	Thrombocytopenia (Thrombopenia) 04/2020 - 08/2011
13	COVID-19 01/2022 - 01/2020
13	Neoplasms (Cancer) 01/2021 - 09/2010
13	Sickle Cell Anemia (Hemoglobin S Disease) 01/2020 - 02/2016
8	Bone Marrow Failure Disorders 01/2018 - 09/2015
7	Infections 01/2022 - 03/2013
7	Acute Chest Syndrome 01/2020 - 04/2016
6	Critical Illness (Critically Ill) 01/2022 - 12/2015
6	Transfusion Reaction 01/2022 - 09/2015
6	Stroke (Strokes) 01/2020 - 01/2017
4	Severe Acute Respiratory Syndrome 01/2021 - 01/2020
4	Coronavirus Infections 01/2021 - 01/2020
4	Cerebral Infarction 01/2020 - 01/2017
3	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021 - 10/2020
3	Hematologic Neoplasms (Hematological Malignancy) 01/2016 - 10/2014
2	Lymphoma (Lymphomas) 01/2021 - 08/2016
2	Infarction (Infarctions) 01/2020 - 01/2017
2	Pulmonary Hypertension 10/2019 - 05/2016
2	Lung Diseases (Lung Disease) 10/2019 - 05/2016
2	Thromboembolism 01/2018 - 03/2016
2	Meningitis 01/2018 - 05/2016
2	Iron Overload 01/2018 - 01/2018
2	Liver Diseases (Liver Disease) 01/2018 - 12/2015
2	Aplastic Anemia (Anemia, Hypoplastic) 09/2016 - 10/2015
2	Mycoses (Diseases, Fungus) 04/2016 - 06/2015
2	Neutropenia 04/2016 - 06/2015
2	Disseminated Intravascular Coagulation 03/2016 - 07/2013
1	Wounds and Injuries (Trauma) 01/2022
1	Cytokine Release Syndrome 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Hematoma 04/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Acute Lung Injury 11/2019
1	Multiple Myeloma 11/2019
1	Polyneuropathies (Polyneuropathy) 11/2019
1	Disease Progression 11/2019

Drug/Important Bio-Agent (IBA)

10	beta-Globins (beta Globin)IBA 01/2020 - 04/2016
8	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2020 - 05/2016
5	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 01/2020
5	Thrombopoietin (c-mpl Ligand)IBA 01/2018 - 01/2014
4	IronIBA 01/2020 - 09/2016
4	Pharmaceutical PreparationsIBA 11/2019 - 05/2016
4	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2018 - 08/2016
4	Fibrinogen (Factor I)FDA Link 10/2016 - 01/2014
3	recombinant FVIIa (rFVIIa)FDA Link 10/2016 - 01/2014
3	Antifibrinolytic Agents (Antifibrinolytics)IBA 03/2016 - 07/2013
2	bamlanivimabIBA 01/2022 - 01/2021
2	casirivimab and imdevimab drug combinationIBA 01/2022 - 01/2021
2	Monoclonal AntibodiesIBA 01/2022 - 01/2021
2	Heparin (Liquaemin)FDA LinkGeneric 08/2021 - 08/2021
2	AntibodiesIBA 01/2021 - 10/2016
2	Tranexamic Acid (AMCA)FDA Link 10/2019 - 10/2016
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2017 - 09/2016
2	Factor VIIa (Activated Factor VII)IBA 10/2016 - 08/2016
2	Dacarbazine (DIC)FDA LinkGeneric 03/2016 - 07/2013
2	Lysine (L-Lysine)FDA Link 03/2016 - 07/2013
1	Oxygen (Dioxygen)IBA 01/2022
1	cilgavimabIBA 01/2022
1	tixagevimabIBA 01/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 08/2021
1	Lopinavir FDA Link 08/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 08/2021
1	Ritonavir (Norvir)FDA Link 08/2021
1	sarilumabIBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	tocilizumab (atlizumab)FDA Link 01/2021
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2021
1	bamlanivimab and etesevimab drug combinationIBA 01/2021
1	regdanvimabIBA 01/2021
1	sotrovimabIBA 01/2021
1	Anesthetics (Anesthetic Agents)IBA 04/2020
1	AnticoagulantsIBA 11/2019
1	Drug CombinationsIBA 11/2019
1	Thymidine Monophosphate (TMP)IBA 11/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2019
1	Lenalidomide (CC 5013)FDA Link 11/2019
1	Bortezomib (Velcade)FDA Link 11/2019
1	Thalidomide (Thalomid)FDA Link 11/2019
1	Melphalan (Alkeran)FDA LinkGeneric 11/2019

Therapy/Procedure

36	Platelet Transfusion (Blood Platelet Transfusions) 01/2020 - 09/2010
21	Therapeutics 01/2022 - 06/2015
18	Drug Therapy (Chemotherapy) 10/2019 - 05/2013
11	Blood Transfusion (Blood Transfusions) 01/2022 - 03/2013
11	Erythrocyte Transfusion 01/2020 - 10/2015
10	Stem Cell Transplantation 10/2019 - 05/2013
7	Blood Component Removal (Apheresis) 01/2018 - 09/2015
5	Secondary Prevention 01/2020 - 01/2017
4	Length of Stay 01/2022 - 01/2017
4	Catheters 04/2020 - 05/2016
3	Central Venous Catheters 04/2020 - 12/2015
2	Critical Care (Surgical Intensive Care) 08/2021 - 01/2017
2	Chelation Therapy (Therapy, Chelation) 01/2018 - 09/2016
2	Consolidation Chemotherapy 03/2016 - 07/2013
2	Hematopoietic Stem Cell Transplantation 01/2016 - 06/2015
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Anesthesia 04/2020
1	Duration of Therapy 11/2019